Related Experiment Videos
Characterization of kappa-opioid receptor transcripts expressed by T cells and macrophages
C Alicea1, S M Belkowski, J K Sliker
1Department of Microbiology and Immunology, Temple University School of Medicine, Philadelphia, PA 19140, USA.
Abstract:
We have found that the immature T cell lines R1.1 and DPK and the macrophage lines P388D1 and WEHI-3 also express kappa-opioid receptor (KOR) mRNA. Characterization of the KOR transcripts in both brain tissue and these T cells has revealed both the normal full-length as well as a truncated form of the mRNA. Our results show that the truncated transcript lacks the second exon. Primary macrophages express this truncated form of the transcript in the absence of detectable levels of the full-length form. These results suggest a degree of heterogeneity in the expression of the opioid receptors which has not previously been reported.
Insights
Immune cells, including T cells and macrophages, express kappa-opioid receptor (KOR) mRNA. Researchers discovered both full-length and truncated KOR mRNA forms, indicating novel receptor heterogeneity.
Area of Science:
- Immunology
- Neuroscience
- Molecular Biology
Background:
- Opioid receptors, particularly the kappa-opioid receptor (KOR), are primarily studied in the central nervous system.
- Previous research has not extensively explored KOR expression in non-neuronal cell types.
Purpose of the Study:
- To investigate the expression of kappa-opioid receptor (KOR) mRNA in immature T cell and macrophage lines.
- To characterize the forms of KOR mRNA present in these immune cells and compare them to brain tissue.
Main Methods:
- Utilized T cell lines (R1.1, DPK) and macrophage lines (P388D1, WEHI-3).
- Performed mRNA characterization of KOR transcripts from both cell lines and brain tissue.
- Analyzed KOR transcripts to identify full-length and truncated forms, including exon composition.
Main Results:
- Immature T cell lines and macrophage lines were found to express KOR mRNA.
- Both full-length and a truncated form of KOR mRNA were identified in T cells and brain tissue.
- Primary macrophages predominantly expressed the truncated KOR mRNA lacking the second exon, with no detectable full-length form.
Conclusions:
- Immune cells possess kappa-opioid receptor (KOR) mRNA expression.
- A novel truncated KOR mRNA transcript, lacking the second exon, is expressed in immune cells, particularly macrophages.
- These findings reveal significant heterogeneity in opioid receptor expression not previously reported.